Systemic quinolones and risk of retinal detachment I: analysis of data from the US FDA adverse event reporting system.

Mohamed Kadry TaherAbdallah AlamiChristopher A GravelDerek TsuiLise M BjerreFranco MomoliDonald MattisonDaniel Krewski

Published in: Expert opinion on drug safety (2021)

Moxifloxacin is the only quinolone showing a positive disproportionality signal for RD. Further epidemiologic research is needed to clarify the association between moxifloxacin and RD risk.

Keyphrases

adverse drug
electronic health record
big data
emergency department